Stereotaxis (STXS) Depreciation & Amortization (CF) (2010 - 2026)
Stereotaxis' (STXS) quarterly Depreciation & Amortization (CF) came in at $159000.0 in Q1 2026, up 1.92% year-on-year from $156000.0 in Q1 2025, and up 0.63% on a QoQ basis from $158000.0 in Q4 2025.
Stereotaxis (STXS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $159000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 1.92% year-over-year to $159000.0 in Q1 2026; TTM through Mar 2026 was $629000.0, a 4.31% increase from a year earlier, with the FY2025 full-year figure at $626000.0, up 6.64% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $159000.0, up from $158000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for STXS reached as high as $160000.0 in Q1 2023 and fell as low as $94000.0 in Q2 2022.
- Historically, Depreciation & Amortization (CF) has averaged $140941.2 across 5 years, with a median of $150000.0 in 2023.
- On a YoY basis, Depreciation & Amortization (CF) climbed as much as 403.85% in 2022 and fell as far as 94.12% in 2022.
- Year by year, Depreciation & Amortization (CF) stood at $131000.0 in 2022, then increased by 5.34% to $138000.0 in 2023, then climbed by 15.22% to $159000.0 in 2024, then declined by 0.63% to $158000.0 in 2025, then increased by 0.63% to $159000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $159000.0 in Q1 2026, $158000.0 in Q4 2025, and $156000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | 159,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Dec 31, 2025 | 158,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Mar 31, 2025 | 156,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Dec 31, 2024 | 159,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Sep 30, 2024 | 152,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Jun 30, 2024 | 136,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Dec 31, 2023 | 138,000.00 |